Strata Critical Medical, Inc.
Close on Oct 19, 2026
- Market cap
- $391.41M
- P/E (TTM)
- 8.9
- Dividend yield
- –
Earnings
Next report expected Nov 9, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 4, 2026 | Before market open | $72.50M | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | Before market open | $67.40M | $0.03 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 3, 2026 | Before market open | $66.79M | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 10, 2025 | Before market open | $49.30M | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | Before market open | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 12, 2025 | Before market open | $54.30M | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 13, 2025 | Before market open | $54.40M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 12, 2024 | Before market open | $74.90M | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 12, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 4, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | 2026 | $33.00M to $35.00M | Raised |
| Free cash flow, before aircraft and engine acquisitionsnon-GAAP | 2026 | $15.00M to $22.00M | Maintained |
| Revenue | 2026 | $285.00M to $295.00M | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Strata Critical Medical filed with the SEC
Strata Critical Medical Announces Second Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Strata Critical Medical Announces First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Strata Critical Medical Announces Fourth Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Strata Announces Closing of Revolving Credit Facility to Support
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Strata Critical Medical, Inc. Appoints Will
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Strata Critical Medical Announces Third Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
Material agreement · Acquisition or disposition completed · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED
Material agreement · Acquisition or disposition completed · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Blade Completes Sale of Passenger
Material agreement · Acquisition or disposition completed · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Blade Air Mobility Announces Second Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
announces sale of Passenger Division to Joby,
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Blade Air Mobility Announces First Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Announces Fourth Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Announces Third Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Announces Second Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the First Quarter Ended March 31, 2024
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Announces $20 Million Share Repurchase Program
Other events · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the Fourth Quarter Ended December 31, 2023
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the Third Quarter Ended September 30, 2023
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the Second Quarter Ended June 30, 2023
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the First Quarter Ended March 31, 2023
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Expands Board of Directors,
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the Fourth Quarter and Calendar Year Ended December 31, 2022
Results of operations · EX-99.1 to Form 8-K
THE COURT OF CHANCERY OF THE STATE OF DELAWARE
Other events · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the Third Quarter Ended September 30, 2022
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the Second Quarter Ended June 30, 2022
Results of operations · EX-99.1 to Form 8-K
Blade to Acquire Three Urban Air Mobility Companies
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the First Quarter Ended March 31, 2022
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Reports Financial Results for the Quarter and Calendar Year Ended December 31, 2021
Results of operations · EX-99.1 to Form 8-K
Blade Air Mobility Reports Fiscal Fourth Quarter And Fiscal Year Ended September 30, 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K
BLADE ACQUIRES EXCLUSIVE RIGHTS TO HELIJET’S
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K